TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

HERITAGE PHARMA AVET

GastroenterologyInfectious Disease
Generics

HERITAGE PHARMA AVET is a generic drug manufacturer focused on Gastroenterology, Infectious Disease. Key products include SERTRALINE HYDROCHLORIDE.

1983
Since
14
Drugs
-
Trials
174
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2025-11-20
Manufacturing (CMC)
RISPERIDONE 2025-11-04
Labeling
TACROLIMUS 2025-10-17
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 50%
1 drugs
Infectious Disease 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Gastroenterology
Bristol-Myers Squibb big-pharma
Gastroenterology, Infectious Disease
APOTHECON specialty
Infectious Disease, Gastroenterology
Gilead Sciences biotech
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Infectious Disease, Gastroenterology